OK BIOTECH (4155) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 訊映

OK BIOTECH (4155) reported revenue of NT$153.3 million for Oct 2026, +19.6% year on year and -29.4% from the previous month. Revenue for Jan–Oct 2026 was NT$1.54 billion (+14.5% year on year).

Year-on-year revenue growth: 5 months in a row. →

In Oct 2026, it ranked No. 54 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$144.7 million24/10Nov 2024 NT$122.7 millionDec 2024 NT$163.4 millionJan 2025 NT$154.7 millionFeb 2025 NT$95.6 million25/02Mar 2025 NT$163.2 millionApr 2025 NT$140.4 millionMay 2025 NT$143.5 millionJun 2025 NT$140.4 million25/06Jul 2025 NT$114.2 millionAug 2025 NT$132.1 millionSep 2025 NT$135.6 millionOct 2025 NT$128.2 million25/10Nov 2025 NT$112.8 millionDec 2025 NT$97.1 millionJan 2026 NT$131.5 millionFeb 2026 NT$105.9 million26/02Mar 2026 NT$146.2 millionApr 2026 NT$127.2 millionMay 2026 NT$139.2 millionJun 2026 NT$172.6 million26/06Jul 2026 NT$152.8 millionAug 2026 NT$197.3 millionSep 2026 NT$217 millionOct 2026 NT$153.3 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$153.3 million+19.6%-29.4%
Sep 2026NT$217 million+60.0%+10.0%
Aug 2026NT$197.3 million+49.3%+29.1%
Jul 2026NT$152.8 million+33.8%-11.5%
Jun 2026NT$172.6 million+22.9%+24.0%
May 2026NT$139.2 million-3.0%+9.5%
Apr 2026NT$127.2 million-9.4%-13.0%
Mar 2026NT$146.2 million-10.4%+38.0%
Feb 2026NT$105.9 million+10.8%-19.4%
Jan 2026NT$131.5 million-15.0%+35.4%
Dec 2025NT$97.1 million-40.6%-13.9%
Nov 2025NT$112.8 million-8.0%-12.0%
Oct 2025NT$128.2 million-11.4%-5.5%
Sep 2025NT$135.6 million-23.8%+2.7%
Aug 2025NT$132.1 million+0.1%+15.7%
Jul 2025NT$114.2 million-21.3%-18.7%
Jun 2025NT$140.4 million-17.5%-2.1%
May 2025NT$143.5 million+16.9%+2.2%
Apr 2025NT$140.4 million-3.7%-14.0%
Mar 2025NT$163.2 million-0.4%+70.7%
Feb 2025NT$95.6 million-7.7%-38.2%
Jan 2025NT$154.7 million+82.4%-5.3%
Dec 2024NT$163.4 million+71.2%+33.2%
Nov 2024NT$122.7 million+30.1%-15.2%
Oct 2024NT$144.7 million+68.0%-18.8%

Jan–Oct 2026 cumulative: NT$1.54 billion (+14.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: OK BIOTECH vs PEC / OK BIOTECH vs Lotus Pharm / OK BIOTECH vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16